Literature DB >> 25944510

Effects of various factors on sleep disorders and quality of life in Parkinson's disease.

Srdjana Telarovic1,2, Dragana Mijatovic3, Irma Telarovic4.   

Abstract

In Parkinson's disease (PD), sleep disorders (SD) occur as a result of the neurochemical changes in sleep centres, neurodegenerative changes in dopaminergic neurons, and other factors. The most common SD include excessive daytime sleepiness, insomnia, restless legs syndrome and nocturia. The aim of the study was to compare quality of sleep, as a factor that greatly impacts quality of life (QoL), between PD patients and a control group and to further examine SD in the PD group with focus on incidence and SD types as well as on effects various factors (age, sex, PD characteristics, medication usage) have on these disorders. The study included 110 patients who met the criteria for the diagnosis of PD and 110 age-matched healthy controls. We used the Pittsburgh Sleep Quality Index, PD Sleep Scale, Epworth Sleepiness Scale, PD QoL Questionnaire-8 and PD Questionnaire-39 (items 30 and 33). In the group with PD, we considered the duration of the disease, the stage of disease according to the Hoehn and Yahr scale, medications and their impact on the SD. The average duration of the disease was 6 years and the mean stage was 2.44. The result showed significant differences in the sleep quality between groups. In the PD group, SD differences were also found according to gender, duration of the disease and medication usage. The most common SD were fragmented sleep, insomnia and nocturia. To improve the QoL of PD patients, it is necessary to pay more attention to detecting and solving SD.

Entities:  

Keywords:  Dopamine agonists; Levodopa; Sleep disorders; Sleep quality

Mesh:

Year:  2015        PMID: 25944510     DOI: 10.1007/s13760-015-0478-0

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  4 in total

1.  Association of sleep disturbance and freezing of gait in Parkinson disease: prevention/delay implications.

Authors:  Xiaohui Tang; Lijia Yu; Jingyun Yang; Wenjing Guo; Ying Liu; Yaling Xu; Xijin Wang
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.062

2.  Activation of the ventral tegmental area increased wakefulness in mice.

Authors:  Huan-Xin Sun; Dian-Ru Wang; Chen-Bo Ye; Zhen-Zhen Hu; Chen-Yao Wang; Zhi-Li Huang; Su-Rong Yang
Journal:  Sleep Biol Rhythms       Date:  2017-02-24       Impact factor: 1.186

3.  High PSQI score is associated with the development of dyskinesia in Parkinson's disease.

Authors:  Xiaohui Tang; Jingyun Yang; Yining Zhu; Haiyan Gong; Hui Sun; Fan Chen; Qiang Guan; Lijia Yu; Weijia Wang; Zengping Zhang; Li Li; Guozhao Ma; Xijin Wang
Journal:  NPJ Parkinsons Dis       Date:  2022-09-29

4.  Insomnia in neurological diseases.

Authors:  Geert Mayer; Svenja Happe; Stefan Evers; Wiebke Hermann; Sabine Jansen; Ulf Kallweit; Maria-Lucia Muntean; Dieter Pöhlau; Dieter Riemann; Michael Saletu; Melanie Schichl; Wolfgang J Schmitt; Friederike Sixel-Döring; Peter Young
Journal:  Neurol Res Pract       Date:  2021-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.